Structure–Activity Relationship of PAD4 Inhibitors and Their Role in Tumor Immunotherapy
Protein arginine deiminase 4 (PAD4) plays an important role in cancer progression by participating in gene regulation, protein modification, and neutrophil extracellular trap (NET) formation. Many reversible and irreversible PAD4 inhibitors have been reported recently. In this review, we summarize t...
Main Authors: | Yijiang Jia, Renbo Jia, Ayijiang Taledaohan, Yanming Wang, Yuji Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-02-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/16/3/335 |
Similar Items
-
Chitosan nanomedicine containing RGD peptide and PAD4 inhibitor based on phenyl boronate coupling inhibition of primary tumor growth and lung metastasis
by: Yijiang Jia, et al.
Published: (2023-12-01) -
RGD Peptide and PAD4 Inhibitor-Loaded Gold Nanorods for Chemo-Photothermal Combined Therapy to Inhibit Tumor Growth, Prevent Lung Metastasis and Improve Biosafety
by: Lu Y, et al.
Published: (2021-08-01) -
TAT-Modified Gold Nanoparticles Enhance the Antitumor Activity of PAD4 Inhibitors
by: Song S, et al.
Published: (2020-09-01) -
Spontaneous Secretion of the Citrullination Enzyme PAD2 and Cell Surface Exposure of PAD4 by Neutrophils
by: Yebin Zhou, et al.
Published: (2017-09-01) -
PAD4 and Its Inhibitors in Cancer Progression and Prognosis
by: Di Zhu, et al.
Published: (2022-11-01)